285 related articles for article (PubMed ID: 24789589)
1. Heart failure in African Americans: disparities can be overcome.
Sharma A; Colvin-Adams M; Yancy CW
Cleve Clin J Med; 2014 May; 81(5):301-11. PubMed ID: 24789589
[TBL] [Abstract][Full Text] [Related]
2. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
3. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Raj L; Adhyaru B
Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
[TBL] [Abstract][Full Text] [Related]
4. Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Echols MR; Yancy CW
Vasc Health Risk Manag; 2006; 2(4):423-31. PubMed ID: 17323596
[TBL] [Abstract][Full Text] [Related]
5. Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.
Ferdinand KC; Serrano CC; Ferdinand DP
Curr Hypertens Rep; 2002 Aug; 4(4):311-8. PubMed ID: 12117459
[TBL] [Abstract][Full Text] [Related]
6. Current medical therapy for advanced heart failure.
Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
[No Abstract] [Full Text] [Related]
7. Heart Failure.
Wu A
Ann Intern Med; 2018 Jun; 168(11):ITC81-ITC96. PubMed ID: 29868816
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Lim WY; Woldman S
Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
[No Abstract] [Full Text] [Related]
9. Evidence-based treatment of chronic heart failure.
Rosen D; Decaro MV; Graham MG
Compr Ther; 2007; 33(1):2-17. PubMed ID: 17984487
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
Ziaeian B; Fonarow GC; Heidenreich PA
JACC Heart Fail; 2017 Sep; 5(9):632-639. PubMed ID: 28711446
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive therapy and management of the transition of care in patients with heart failure.
Feitell S; Hankins SR; Eisen HJ
Cardiol Clin; 2014 Feb; 32(1):163-74, x. PubMed ID: 24286587
[TBL] [Abstract][Full Text] [Related]
13. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
Colvin-Adams M; Taylor AL
Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
[TBL] [Abstract][Full Text] [Related]
14. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in heart failure therapeutics.
Ishizawar D; Yancy C
Heart Fail Clin; 2010 Jan; 6(1):65-74. PubMed ID: 19945062
[TBL] [Abstract][Full Text] [Related]
16. BiDil: primary care physicians first and cardiologist when?
Matthews GE
J Natl Med Assoc; 2007 Jun; 99(6):697-9; quiz 700. PubMed ID: 17595944
[No Abstract] [Full Text] [Related]
17. Dilemmas With Race and Heart Failure Treatment.
Butler J; Konstam MA
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707751
[No Abstract] [Full Text] [Related]
18. [Chronic heart failure: how can the family doctor put current guidelines into practice?].
Finsterer S; Weyerbrock S; Basler M; Mühling H; Silber S
MMW Fortschr Med; 2008 Mar; 150(12):29-33. PubMed ID: 18533593
[No Abstract] [Full Text] [Related]
19. Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
Pharmacogenomics; 2005 Jul; 6(5):455. PubMed ID: 16705760
[No Abstract] [Full Text] [Related]
20. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
